DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus (Q34958192)

5 August 2017

DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus (English)

1 reference

5 August 2017

1 reference

1 reference

Jean S Wang

1

1 reference

5 August 2017

Mingzhou Guo

2

1 reference

5 August 2017

Elizabeth A Montgomery

3

1 reference

5 August 2017

Richard E Thompson

4

1 reference

5 August 2017

Hilary Cosby

5

1 reference

5 August 2017

Lisa Hicks

6

1 reference

5 August 2017

Shelun Wang

7

1 reference

5 August 2017

James G Herman

8

1 reference

5 August 2017

Marcia I Canto

9

1 reference

5 August 2017

language of work or name

English

0 references

publication date

7 July 2009

1 reference

The American Journal of Gastroenterology

5 August 2017

1 reference

5 August 2017

104

1 reference

5 August 2017

9

1 reference

5 August 2017

2153-2160

1 reference

Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Central adiposity and risk of Barrett's esophagus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

A gene hypermethylation profile of human cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

The Vienna classification of gastrointestinal epithelial neoplasia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

How does DNA methylation repress transcription?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Barrett's esophagus and adenocarcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Barrett's esophagus. Prevalence and incidence of adenocarcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applications

8 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.300

Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.300

Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.300

Risk factors for Barrett's esophagus: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.300

Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.300

Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.300

Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.300

Aberrant Hypermethylation of Tumor Suppressor Genes in Pancreatic Endocrine Neoplasms

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

DNA methylation and epigenetic mechanisms of carcinogenesis.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090447

An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus

26 October 2018

1 reference

12 December 2020

Aspirin and reduced risk of esophageal carcinoma

1 reference

12 December 2020

p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas

1 reference

12 December 2020

Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus

1 reference

12 December 2020

The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry

1 reference

12 December 2020

Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation

1 reference

12 December 2020

Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung

1 reference

12 December 2020

Methylation of exon 2 of p16 is associated with late stage oesophageal cancer

1 reference

12 December 2020

Aberrant methylation of gene promoters in cancer---concepts, misconcepts, and promise

1 reference

12 December 2020

Predicting lung cancer by detecting aberrant promoter methylation in sputum

1 reference

12 December 2020

Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia

1 reference

12 December 2020

p53 and neoplastic progression in Barrett's esophagus

1 reference

12 December 2020

p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression

1 reference

12 December 2020

Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia

1 reference

12 December 2020

p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium

1 reference

12 December 2020

p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus

1 reference

12 December 2020

Adenocarcinoma and Barrett's esophagus. An overrated risk?

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2009.300

1 reference

5 August 2017

1 reference

5 August 2017

1 reference